|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1994-2-17
|
|
pubmed:abstractText |
Interleukin-3, a recombinant cytokine with multilineage stimulatory effect on hematopoietic cells, was administered to 22 previously untreated breast cancer patients following high-dose therapy with cyclophosphamide (7 g/m2).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
759-66
|
|
pubmed:dateRevised |
2007-1-29
|
|
pubmed:meshHeading |
pubmed-meshheading:8280657-Adolescent,
pubmed-meshheading:8280657-Adult,
pubmed-meshheading:8280657-Bone Marrow,
pubmed-meshheading:8280657-Breast Neoplasms,
pubmed-meshheading:8280657-Child,
pubmed-meshheading:8280657-Cyclophosphamide,
pubmed-meshheading:8280657-Erythrocyte Transfusion,
pubmed-meshheading:8280657-Female,
pubmed-meshheading:8280657-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:8280657-Hematopoiesis,
pubmed-meshheading:8280657-Humans,
pubmed-meshheading:8280657-Interleukin-3,
pubmed-meshheading:8280657-Male,
pubmed-meshheading:8280657-Middle Aged,
pubmed-meshheading:8280657-Recombinant Proteins
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy.
|
|
pubmed:affiliation |
Cristina Gandini Bone Marrow Transplantation Unit, Istituto Nazionale Tumori, Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
